The metabolic breakdown of inhalation anaesthetics and their clinical implications
Halsey, M.J.
Acta Anaesthesiologica Belgica 24(2): 109-114
1973
ISSN/ISBN: 0001-5164 PMID: 4146216 Document Number: 57612
Document emailed within 1 workday
Related Documents
Husum, B.; Wulf, H.C.; Niebuhr, E. 1982: Sister chromatid exchanges in humans exposed to inhalation anaesthetics Progress in Clinical and Biological Research 109: 465-470Baden, J.M.; Kelley, M.; Mazze, R.I.; Simmon, V.F. 1979: Mutagenicity of inhalation anaesthetics: trichloroethylene, divinyl ether, nitrous oxide and cyclopropane British Journal of Anaesthesia 51(5): 417-421
Baron, J.C. 1994: Consequences of lesions of the basal ganglia on cerebral metabolic activity: clinical implications Revue Neurologique (Paris) 150(8-9): 599-604
Yamagishi, M.; Tanaka, H.; Yokogawa, K.; Sugaya, F.; Honma, S.; Honma, A.; Shijubo, N.; Abe, S. 1993: High dose steroid inhalation therapy using a large spacer: laboratory and clinical study on usefulness of the 4-puffs/inhalation method Nihon Kyobu Shikkan Gakkai Zasshi 31(10): 1235-1244
Niedermaier, J.; Moritz, K.B. 2000: Organization and dynamics of satellite and telomere DNAs in Ascaris: implications for formation and programmed breakdown of compound chromosomes Chromosoma 109(7): 439-452
Mitrovic, D.R.; Gruson, M.; Ryckewaert, A. 1981: Local hyperthermia and cartilage breakdown: histochemical and metabolic studies on rabbit articular cartilage in vitro Journal of Rheumatology 8(2): 193-203
Hagami, E.; Shishido, F.; Kanno, I.; Uemura, K.; Higano, S. 1991: 15O2 inhalation method: cerebral metabolic rate of oxygen (CMRO2) Nihon Rinsho. Japanese Journal of Clinical Medicine 49(7): 1502-1508
Kodama, K. 1971: Metabolic effects of hyperventilation and carbon dioxide inhalation during halothane anesthesia Masui. Japanese Journal of Anesthesiology 20(12): 1148-1162
Fujita, T. 1982: Clinical study of complement breakdown products in patients with hypocomplementemic glomerulonephritis Nihon Jinzo Gakkai Shi 24(8): 845-853
Ena, I.M.; Chernysheva, L.G.; Taran, A.I.; Shevchenko, L.I. 1981: Clinical importance of determining fibrinogen and fibrin breakdown products in arterial hypertension Sovetskaia Meditsina 1981(3): 6-9
Perrini, S.; Carreira, M.C.; Conserva, A.; Laviola, L.; Giorgino, F. 2008: Metabolic implications of growth hormone therapy Journal of Endocrinological Investigation 31(9 Suppl): 79-84
Wolfe, R.R. 1993: Metabolic response to burn injury: nutritional implications Seminars in Nephrology 13(4): 382-390
Kurabayashi, Y.; Yasuji, T.; Hirakawa, M.; Shioaku, Y.; Yokota, T. 1975: Effect of iron particle inhalation and its treatment--with special reference to inhalation therapy and its therapeutic effects Masui. Japanese Journal of Anesthesiology 24(1): 78-83
Carabez Trejo, A. 1994: The inhalation of industrial solvents. the effect of the chronic inhalation of thinner on the rat liver and on an isolated mitochondrial fraction Gaceta Medica de Mexico 130(5): 335-346
Strobel, K. 1972: Pyrogen studies on inhalation-waters using intravenous injection and inhalation Das Deutsche Gesundheitswesen 27(34): 1618-1623
Solt, D.B. 1991: The pathogenesis, oral manifestations, and implications for dentistry of metabolic bone disease Current Opinion in Dentistry 1(6): 783-791
Levy, H.L. 1996: Reproductive effects of maternal metabolic disorders: implications for pediatrics and obstetrics Turkish Journal of Pediatrics 38(3): 335-344
Martins, M.C.; Abi-Rached, R.S.G.; Shibli, J.A.; Araujo, M.W.B.; Marcantonio, E. 2004: Experimental peri-implant tissue breakdown around different dental implant surfaces: clinical and radiographic evaluation in dogs International Journal of Oral and Maxillofacial Implants 19(6): 839-848
Fiuza, M.; Cortez-Dias, N.; Martins, S.; Belo, A.; Dias, A.D.C.; Neves, A.S.; Frazão, A.é; Pereira, A.ón.A.P.; Do Vale, A.ón.F.M.; Dias Simas, A.M.; Estrela, C.; Amorim, E.A.; Almeida, F.E.M.; Amaral, G.M.B.; Silva, I.M.S.; Sousa, J.M.M.; Morgado, J.M.O.; Santos, J.é C.O.; Senra, J.é F.M.; Amaral, L.G.M.; Aleixo, L.G.; Soares, L.M.S.; Cafede, M.C.F.A.; Colleo, M.O.M.C.; Senra, M.C.M.; Ramiro, M.J.R.C.C.; Borges, M.M.S.A.P.; Amaral, P.N.P.; Andrade, R.M.L.; Costa, R.P.D.R.C.; Conde, A.I.; Rodrigues, A.; Santana, A.; Morais, A.S.; Cardoso, A.A.M.V.; Barros, A.; Perez, A.; Matias, A.; Carina, A.; Cardoso, A.M.C.S.E.; Dinis, A.R.F.; Santana, A.; Baltazar, A.; Vieira, A.ón.J.é C.; Farias, A.M.; Martins, A.V.; Magalhães, A.M.B.; Graça,; 2008: Metabolic syndrome in Portugal: prevalence and implications for cardiovascular risk--results from the VALSIM Study Revista Portuguesa de Cardiologia: Orgao Oficial da Sociedade Portuguesa de Cardiologia 27(12): 1495-1529
Zheng, X.; Wang, G-ji.; Hao, H-ping. 2017: Update on immune and metabolic dysregulation in major depressive disorder and the implications for drug intervention Yao Xue Xue Bao 52(1): 19-25